PANAGORA ASSET MANAGEMENT INC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$958,000
+447.4%
49,123
+358.8%
0.01%
+400.0%
Q4 2021$175,000
-88.6%
10,707
-78.6%
0.00%
-83.3%
Q1 2018$1,538,000
+15280.0%
49,934
+12670.8%
0.01%
Q2 2017$10,000
-82.5%
391
-77.9%
0.00%
Q2 2015$57,000
-95.5%
1,771
-95.2%
0.00%
-100.0%
Q2 2014$1,262,000
+3.9%
37,118
-3.8%
0.01%0.0%
Q1 2014$1,215,00038,5730.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$42,779,00061.17%
Essex Woodlands Management, Inc. 3,342,047$91,739,00021.30%
Sio Capital Management, LLC 101,292$2,780,0001.54%
Fosun International Ltd 472,532$12,971,0000.66%
Rhenman & Partners Asset Management AB 203,181$5,577,0000.57%
ArrowMark Colorado Holdings LLC 1,804,275$49,527,0000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 87,355$2,398,0000.30%
FOX RUN MANAGEMENT, L.L.C. 18,477$507,0000.16%
Phoenix Investment Adviser LLC 2,400$66,0000.12%
Quinn Opportunity Partners LLC 33,100$909,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders